Stevanato Group S.p.A.

US$13.57As of Sun 8 Nov 2026, 12:00 UTC
NYSE:STVNHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (6.99%)
Div yield 0.44%
ROE 9.26%
Medical Instruments & Supplies
Beta (5Y) 0.80
PE TTM 23.43
TSR TTM (46.00%)
Mkt cap US$3.706B
ROIC 8.03%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$17
28.21%
(6.14%)
Hold 4|5|3|10|3
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.26
0.28
0.30
0.34
15.42%
20.24%
33.77%
35.42%
Revenue€M
247.0
253.1
256.0
250.1
6.01%
7.40%
9.98%
4.63%
Peers (US$3.706B)
Cap (US$)
PE
4.593B
30.72x
1.437B
25.35x
953.5M
16.83x
Capital
TTM
5Y
10Y
Leveragex
1.534
(0.035)
(0.035)
EBIT/Intx
0.116
0.297
0.268
Own earn%
154.03
(35.40)
(33.37)
Sh yield%
24.20
25.32
24.61
Owners
Insiders/Inst%
4.42
68.05
Short interest%
4.54
SBC / revenue%
3.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
25–30
$1 testx
—
Incr. ROIC%
27